When Bipolar Disorder Presents, Consider Cardiovascular Comorbidities
Screening for cardiovascular disease risk is recommended for clinicians who manage patients with bipolar disorder.
All articles by Suzanne Bujara
Transcranial Direct Current Stimulation Promising for Major Depressive Disorder
With better understanding of the underlying mechanisms of transcranial direct current stimulation, clinicians will be better equipped to identify the optimal management of their patients with major depressive disorder.
Comorbid Bipolar Disorder and Substance Abuse: A Challenge to Diagnose and Treat
Bipolar disorder is often comorbid with substance use disorders, with alcohol being the top substance. Clinicians should take a thorough history to uncover substance use disorder because it will guide the management of both disorders.
Bipolar Disorder in the Perinatal Period: No Consensus on Treatment
Before the next set of guidelines are updated and harmonized, individual studies may provide direction for clinicians.
The Psychosocial Impact of Rosacea: Should Clinicians Be Concerned?
The erythematotelangiectatic, papulopustular, phymatous, and ocular forms of rosacea can lead to psychological distress.
Substance Abuse and Primary Psychosis: A Closer Look
Patients will still be at risk for schizophrenia or bipolar disorder even several years after an episode of substance-induced psychosis.
Why Treating Major Depressive Disorder Improves Outcomes in HIV
Mental health problems are 1 of the most important reasons for failing to engage in long-term control of HIV.
Video Games and Exercise as Alternative Therapies for ADHD
ADHD’s many deficits cannot be ameliorated by pharmacotherapy alone. Researchers and clinicians are investigating computer interventions and physical activity that get to the root of the ADHD domain, such as inattention, memory, or time management.
Potential for SERMs as Adjunctive Therapy for Schizophrenia
Raloxifene has demonstrated mostly positive results in meta-analyses of men and women with schizophrenia who received the selective estrogen receptor modulator as adjunctive therapy.
The Way to the Head May Be Through the Gut: Probiotics for Depression
Although the theory of the gut-brain axis has existed for more than a century, recent studies are now examining how gut microbiota influence mood.
Next post in Depression Advisor
